WVU cancer researcher participates in study that shows promising treatments for certain patients with advanced colorectal cancer
A group of cancer researchers, including Richard Goldberg, M.D., director of the WVU Cancer Institute, released a study today (June 20) in the Journal of the American Medical Association comparing the results of combinations of chemotherapy delivered with targeted therapy drugs in the treatment of people with advanced colorectal cancer who had not received prior drug treatment for their advanced disease.